Medytox to supply $73 mn botulinum toxin to Brazilian firm

It signed a contract with local pharmaceutical company Blau to provide products including Newlux for five years

Medytox to supply mn botulinum toxin to Brazilian firm
Yoo-Rim Kim 1
2024-03-26 15:56:16 youforest@hankyung.com
Bio & Pharma

South Korea's biopharmaceutical firm Medytox Inc. announced on Tuesday that it signed a contract with Brazilian pharmaceutical company Blau Farmaceutica SA to supply $73 million worth of botulinum toxin products over five years. 

According to the company, Blau signed this contract while acquiring Medytox's existing Brazilian partner, Bergamo.

Under the terms of the deal, Medytox will supply botulinum toxin products, including "Newlux," to Blau, which will sell them locally in Brazil.

Medytox entered Brazil in 2010 with its botulinum toxin product Meditoxin and exported over 20 billion won products last year. This accounted for 30% of Medytox's total toxin exports.

Write to Yoo-Rim Kim at youforest@hankyung.com
#Medytox #Blau Farmaceutica #botulinum toxin #Bergamo #Newlux #Meditoxin

Medytox establishes US subsidiary Luvantas

Medytox establishes US subsidiary Luvantas

South Korean pharmaceutical company Medytox Inc. announced on Wednesday that its establishment of the US subsidiary Luvantas.The goal is the global market entry of its non-animal-derived liquid toxin formulation MT10109L (ingredient name: NivobotulinumtoxinA)  for which it has applied for

Medytox to enter China’s botulinum toxin market with Newlux

Medytox to enter China’s botulinum toxin market with Newlux

South Korean pharmaceutical company Medytox Inc. on Tuesday announced its plan to enter the Chinese market for botulinum toxins (BTX) with its cutting-edge product Newlux developed by affiliate Numeco.Medytox will thus retract its application for imported drug registration for Meditoxin, who

Dubai delegation conducts due diligence on Medytox's plant in Korea

Dubai delegation conducts due diligence on Medytox's plant in Korea

DSP CEO Marwan Abdulaziz Janahi (second from left) at Medytox's Osong plant in South Korea(Courtesy of Medytox) South Korea's biopharmaceutical firm Medytox Inc. said on Monday that a high-level delegation led by Dubai Science Park (DSP) under Dubai's state-owned Tecom Group conducted due dilig

Korean court rules Daewoong poached Medytox’s botox strain

Korean court rules Daewoong poached Medytox’s botox strain

Korean botox maker Medytox A South Korean court on Friday ruled in favor of Medytox Inc. in a civil lawsuit against its crosstown rival Daewoong Pharmaceutical Co. over the source of its botulinum toxin, more commonly known as botox.The Seoul Central District Court accepted Medytox’s clai

Medytox to build plant for finished toxin products in Dubai

Medytox to build plant for finished toxin products in Dubai

Marwan Abdulaziz Janahi, CEO of Dubai Science Park(left) and Jung Hyunho, CEO of Medytox South Korea's biopharmaceutical company Medytox Inc. will build a plant for finished products containing botulinum toxin in the United Arab Emirates (UAE) in what will be the first such facility abroad cons
(* comment hide *}